TL;DR:
- The price of the network’s native token, Injective, stood at $9.13 at the close of October 16, 2026, after recording a daily increase of 27.3% according to CoinGecko records.
- The protocol’s market capitalization climbed to approximately $914 million, with a transaction volume exceeding $340 million over the course of 24 hours.
- The recent expansion coincided with direct meetings between project executives and United States regulators, as well as the incorporation of Gulf Labs as an institutional validator on the network.
During the session on Friday, October 16, the price of the native token Injective surged to reach $9.13, reflecting an upward movement of 27.3% in the last twenty-four hours.
Injective CEO @ericinjective met with officials from the White House, SEC and CFTC in Washington yesterday. He was joined by our General Counsel, Head of Policy and Head of Research.
Injective has quietly built the foundation for tokenization to thrive in America, inside the… pic.twitter.com/Gxt2KIgBAN
— Injective 🥷 (@injective) October 15, 2026
With this price action, the asset positioned itself at rank 85 by total capitalization, with a daily volume exceeding $340 million and a circulating supply established at 100 million units. The daily operating range spanned from a low of $7.07 to a high of $9.35, while the current price level remains 82.6% below its all-time high of $52.62 recorded in previous cycles.
Market data indicated that the daily increase fits into a broader recovery period, where the price accumulated a rise close to 70% during the previous thirty days from the $5.40 zone. Market analysts observed a reduction in balances held on centralized exchanges, a movement linked to the transfer of assets to long-term custody wallets by holders.
Institutional Dialogues and Regulatory Framework
The development of the session was marked by official confirmation of high-level meetings in Washington. A sector source revealed that the company’s CEO, Eric Chen, along with legal counsel and directors of policy and research, met on October 15 with representatives of the White House, the SEC, and the CFTC.
Official documentation indicated that the main topics revolved around asset tokenization and the integration of decentralized finance within the current US regulatory structure. The protocol’s leadership pointed out that these conversations seek to align technological infrastructure with regulatory requirements for institutional operators.
Regulatory background of the project includes the registration of Injective Institutional Services with the SEC in August 2026 as a transfer agent. The measure empowers the subsidiary to manage official records of securities ownership under applicable regulations, provided federal compliance standards are met.
Partnerships in the Asian Ecosystem and Financial Products
On the Asian operational front, Gulf Labs —the digital asset division of GULF Group in Thailand— began operating as an institutional validator node on the network at the beginning of October. Information disseminated by the protocol detailed that the cooperation includes transaction validation, decentralized governance, and the joint development of initiatives regarding tokenization, stablecoins, and energy connectivity.
Spokespersons for Gulf Labs stated that the integration of the business group’s infrastructure with the public network seeks to boost institutional access to financial instruments based on distributed ledger technology. Additionally, asset management entities such as 21Shares and Canary Capital maintain pending applications before the SEC for the authorization of exchange-traded funds linked to the cryptocurrency, including staking options in validation networks.
The evolution of the protocol will depend on the ecosystem’s ability to consolidate corporate adoption channels and meet the regulatory expectations raised in various international markets during the coming months.
Be the first to comment